Episode 51: The State of Sleep Medicine
Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Karl Doghramji, MD, FAASM, DFAPA.
Episode 51 of the NeurologyLive®
The Mind Moments™ podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis (MS), Parkinson disease, dementia, sleep disorders, and more.
Episode 51, "The State of Sleep Medicine," features an exclusive interview with Karl Doghramji, MD, FAASM, DFAPA, professor of psychiatry and human behavior; professor of neurology; and medical director, Jefferson Sleep Disorders Center, at the
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Phase 3 PHOENIX Study of AMX0035 in ALS Gets Under Way FDA Approves First Oral Solution of Topiramate to Treat Epilepsy, Migraines Robert Califf, MD, Nominated by Biden Administration as Next FDA Commissioner
EPISODE BREAKDOWN
1:15 – The role of sleep in individuals' emotional and physical lives
5:40 – Current awareness about the health effects of poor sleep
8:15 – Clinical and commercial tools to measure sleep
10:45 – Recent advances in therapeutics for sleep disorders
15:20 – Tailoring specific therapies for specific patients
17:15 – Neurology News Minute
19:45 – Narcolepsy as a model for other sleep disorders
22:20 – Patient identification and differential diagnosis
25:40 – The sleep specialist's inclusion in the comprehensive care model
28:25 – Meeting the increasing demand for sleep specialists
30:40 – Sleep's role in dementia and cognition
33:50 – The state of sleep amid the COVID-19 pandemic
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
